MC
DH icon

Maplelane Capital’s Definitive Healthcare DH Stock Holding History

Maplelane Capital’s Portfolio DH Stock Details DH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-126,000
Closed -$5.4M – 74
2021
Q3 		$5.4M Buy
+126,000
New +$5.59M 0.18% 76

Other funds holding DH

AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
SEM
Spectrum Equity Management San Francisco, California $39.1M AUM 63.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ESCM
Echo Street Capital Management New York $747M AUM 24.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Maplelane Capital's DH Position: Q4 2021 in Review

Maplelane Capital sold out of Definitive Healthcare (DH) in Q4 2021, closing a stake of 126,000 shares — an estimated $5.4M sold.

Maplelane Capital first reported a position in DH in Q3 2021 and held it in 1 quarter. The position peaked at $5.4M in Q3 2021. 92 funds tracked by Wall St. Rank hold DH as of Q4 2021.

  • Maplelane Capital reported no remaining Definitive Healthcare position as of Q4 2021 after selling out during the quarter.
  • Maplelane Capital sold 126,000 Definitive Healthcare shares in Q4 2021, an estimated $5.4M.
  • Maplelane Capital first reported a position in Definitive Healthcare in Q3 2021 and held it in 1 quarter.
  • Maplelane Capital's Definitive Healthcare position peaked at $5.4M in Q3 2021.
  • 92 funds tracked by Wall St. Rank held Definitive Healthcare as of Q4 2021.

Based on Maplelane Capital's 13F filing for Q4 2021, filed 14 Feb 2022.